Actively Recruiting

Age: 18Years +
All Genders
NCT06758921

Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)

Led by Biotronik AG · Updated on 2025-01-06

200

Participants Needed

16

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the standard of care practices, procedural outcomes, and in-hospital complications for endovascular peripheral interventions of femoral, popliteal and infrapopliteal lesions.

CONDITIONS

Official Title

Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject 18 years old or older
  • Subject has provided written informed consent
  • Subject has Rutherford classification 2 to 6
  • Reference vessel diameter between 2 and 7 mm
  • Target lesion(s) has stenosis greater than 70% by visual assessment
  • Multiple consecutive single lesions with a healthy segment of 3 cm or less in-between will be considered one lesion
  • For above the knee group: Target lesions located in the superficial femoral artery or popliteal arteries (above the tibial plateau)
  • At least one below-knee artery patent to the ankle
  • Successful treatment of inflow iliac stenosis to the target lesion with residual stenosis 30% or less and no embolization or significant complications
  • For below the knee group: Target lesions involve arteries below the tibial plateau
  • Successful treatment of inflow vessel (from ipsilateral iliac to the target lesion) resulting in residual stenosis 30% or less with no embolization or significant complications
Not Eligible

You will not qualify if you...

  • Subject has a single target lesion that involves both above and below the knee segments
  • Subject not suitable for receiving endovascular procedures of lower limb arteries
  • Prior planned major amputation in the target limb (above the ankle)
  • Subject with previous bypass surgery of target vessel
  • History of any open surgical procedure within the past 30 days
  • Planned vascular surgery procedure within the next 30 days after the procedure on the target limb
  • Subject has Oscar IFU listed contraindication such as uncorrected bleeding disorders or sepsis
  • Subject under dialysis
  • Subject currently enrolled in another investigational device, biologic, or drug trial with unresolved primary endpoint
  • Subject lacking capacity to provide informed consent
  • Subject under judicial protection, tutorship, or curatorship (for France only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

LKH Univ. -Klinikum Graz, Ambulanz für Angiologie

Graz, Austria, 8036

Actively Recruiting

2

Onze Lieve Vrouwziekenhuis

Aalst, Belgium, 9300

Not Yet Recruiting

3

AZ Saint Blasius

Dendermonde, Belgium, 9200

Actively Recruiting

4

ZOL Ziekenhuis Oost Limburg

Genk, Belgium, 3600

Not Yet Recruiting

5

University Hospital Ghent

Ghent, Belgium, 9000

Not Yet Recruiting

6

vzw AZ Groeninge

Kortrijk, Belgium, 8500

Not Yet Recruiting

7

Hopital Saint Joseph

Paris, France, 75674

Not Yet Recruiting

8

Karolinen-Hospital Arnsberg

Arnsberg, Germany, 59759

Not Yet Recruiting

9

Sankt Gertrauden-Krankenhaus

Berlin, Germany, 10713

Not Yet Recruiting

10

Universitätsklinikum Tübingen

Tübingen, Germany, 72076

Not Yet Recruiting

11

Semmelweis University

Budapest, Hungary, 1085

Not Yet Recruiting

12

Policlinico Abano Terme

Abano Terme, Italy, 35031

Not Yet Recruiting

13

Azienda Usl Toscana sud est

Arezzo, Italy, 52100

Not Yet Recruiting

14

ospedaliero-universitaria Senese

Siena, Italy, 53100

Not Yet Recruiting

15

Hospital Universitario de Guadalajara

Guadalajara, Spain, 19002

Not Yet Recruiting

16

Ospedale Regionale civico EOC di Lugano

Lugano, Switzerland, 6962

Not Yet Recruiting

Loading map...

Research Team

H

Helene Kuissu, PharmD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First) | DecenTrialz